Program spending to increase adherence: South African cervical cancer screening

PLoS ONE

Volumn 4, Issue 5, 2009, Pages

  Goldhaber Fiebert, Jeremy D ^a,b   Denny, Lynette A ^c   De Souza, Michelle ^e   Kuhn, Louise ^d   Goldie, Sue J ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d Vagelos College of Physicians and Surgeons   (United States)

^e Khayelitsha Cervical Cancer Screening Project (KCCSP)   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COMMUNITY CARE; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE PERSONNEL MANAGEMENT; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PATIENT ATTITUDE; PROFESSIONAL PRACTICE; RESOURCE ALLOCATION; SOUTH AFRICA; UTERINE CERVIX CANCER; CANCER DIAGNOSIS; ECONOMICS; HEALTH AUXILIARY; HEALTH CARE COST; MASS SCREENING; MIDDLE AGED; PRACTICE GUIDELINE; UTERINE CERVIX TUMOR;

ADULT; AGED; COMMUNITY HEALTH AIDES; EARLY DETECTION OF CANCER; FEMALE; GUIDELINE ADHERENCE; HEALTH CARE COSTS; HUMANS; MASS SCREENING; MIDDLE AGED; SOUTH AFRICA; UTERINE CERVICAL NEOPLASMS;

EID: 66549105180     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005691     Document Type: Article

References (29)

1. Beaglehole R, Epping-Jordan J, Patel V, Chopra M, Ebrahim S, et al. (2008) Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care. Lancet 372: 940-949.
2. Cleemput I, Kesteloot K (2002) Economic implications of non-compliance in health care. Lancet 359: 2129-2130.
3. Hirsch-Moverman Y, Daftary A, Franks J, Colson PW (2008) Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis 12: 1235-1254.
4. Liu Q, Abba K, Alejandria MM, Balanag VM, Berba RP, et al. (2008) Reminder systems and late patient tracers in the diagnosis and management of tuberculosis. Cochrane Database Syst Rev: CD006594.
5. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, et al. (1998) Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 36: 1138-1161.
6. Stirratt MJ, Gordon CM (2008) Adherence to biomedical HIV prevention methods: considerations drawn from HIV treatment adherence research. Curr HIV/AIDS Rep 5: 186-192.
7. van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, et al. (2007) Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res 7: 55.
8. Volmink J, Garner P (2000) Interventions for promoting adherence to tuberculosis management. Cochrane Database Syst Rev: CD000010.
9. Yabroff KR, Kerner JF, Mandelblatt JS (2000) Effectiveness of interventions to improve follow-up after abnormal cervical cancer screening. Prev Med 31: 429-439.
10. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
11. Parkin DM, Bray F (2006) Chapter 2: The burden of HPV-related cancers. Vaccine 24 Suppl 3: S3/11-25.
12. Kitchener HC, Castle PE, Cox JT (2006) Chapter 7: Achievements and limitations of cervical cytology screening. Vaccine 24 Suppl 3: S3/63-70.
13. National Guidelines on Cervical Cancer: Screening Programme. South Africa: Department of Health.
14. Denny L (2006) Cervical cancer: the South African perspective. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95 Suppl 1: S211-214.
15. Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, et al. (2006) Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine 24 Suppl 3: S3/78-89.
16. Denny L, Quinn M, Sankaranarayanan R (2006) Chapter 8: Screening for cervical cancer in developing countries. Vaccine 24 Suppl 3: S3/71-77.
17. Koutsky LA, Harper DM (2006) Chapter 13: Current findings from prophylactic HPV vaccine trials. Vaccine 24 Suppl 3: S3/114-121.
18. Schiller JT, Castellsague X, Villa LL, Hildesheim A (2008) An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine 26 Suppl 10: K53-61.
19. Goldhaber-Fiebert JD, Denny LE, De Souza M, Wright TC Jr, Kuhn L, et al. (2005) The costs of reducing loss to follow-up in South African cervical cancer screening. Cost Eff Resour Alloc 3: 11.
20. Denny L, Kuhn L, De Souza M, Pollack AE, Dupree W, et al. (2005) Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA 294: 2173-2181.
21. (2006) The population register update: Khayelitsha 2005: http://www.capegateway.gov.za/other/2007/10/ kprufinal_2005_october_2007_publish_-date.pdf. Cape Town: Maverick 358 cc, Sub-Directorate Population Development in the Research and Population Directorate, Department of Social Services and Poverty Alleviation.
22. (2001) Census 2001: http://www.statssa.gov.za/census01/HTML/default.asp. Statistics South Africa.
23. (2005) World Development Indicators. Washington, D.C.: The World Bank.
24. Goldie SJ, Kuhn L, Denny L, Pollack A, Wright TC (2001) Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. JAMA 285: 3107-3115.
25. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, et al. (2005) Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 353: 2158-2168.
26. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, et al. (2005) Supplement to: Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 353: 2158-2168.
27. (2008) Bicycling Bike Town assists MaAfrika Tikkun. South Africa: MaAfrika Tikkun.
28. Schneider H, Hlophe H, van Rensburg D (2008) Community health workers and the response to HIV/AIDS in South Africa: tensions and prospects. Health Policy Plan 23: 179-187.
29. Shackleton S-J (2007) Rapid Assessment of Cell Phones for Development. South Africa: UNICEF.